Pacific Edge up 6% as Kaiser adopts second product

Pacific Edge up 6% as Kaiser adopts second product
Staff reporters
Shares of Pacific Edge jumped more than 6% after it announced healthcare giant Kaiser Permanente would begin using its Cxbladder triage product from July.Kaiser approved commercial use of Cxbladder products last June, beginning with monitor which is a regular test for those who have previously been treated for bladder cancer.The US health insurance firm told Pacific Edge it plans to begin using the triage product – for patients showing possible symptoms of bladder cancer – in a single clinic comprising six urologists next month.A st...